ADE LLC’s Amgen AMGN Stock Holding History

ADE LLC’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$924K	Hold	2,551	–	–	0.39%	35
2026 Q1	$897K	Hold	2,551	–	–	0.43%	31
2025 Q4	$835K	Hold	2,551	–	–	0.4%	33
2025 Q3	$720K	Hold	2,551	–	–	0.36%	37
2025 Q2	$712K	Buy	2,551 +1,351	+113%	+$383K	0.38%	37
2025 Q1	$374K	Hold	1,200	–	–	0.22%	55
2024 Q4	$313K	Hold	1,200	–	–	0.19%	62
2024 Q3	$387K	Hold	1,200	–	–	0.24%	50
2024 Q2	$375K	Hold	1,200	–	–	0.25%	50
2024 Q1	$341K	Hold	1,200	–	–	0.23%	57
2023 Q4	$346K	Hold	1,200	–	–	0.24%	55
2023 Q3	$323K	Hold	1,200	–	–	0.24%	54
2023 Q2	$266K	Hold	1,200	–	–	0.19%	68
2023 Q1	$290K	Hold	1,200	–	–	0.21%	62
2022 Q4	$315K	Hold	1,200	–	–	0.24%	58
2022 Q3	$270K	Hold	1,200	–	–	0.3%	47
2022 Q2	$292K	Hold	1,200	–	–	0.31%	45
2022 Q1	$290K	Hold	1,200	–	–	0.27%	54
2021 Q4	$270K	Hold	1,200	–	–	0.23%	65
2021 Q3	$255K	Hold	1,200	–	–	0.23%	60
2021 Q2	$293K	Hold	1,200	–	–	0.27%	56
2021 Q1	$299K	Hold	1,200	–	–	0.3%	52
2020 Q4	$276K	Buy	+1,200	New	+$277K	0.22%	61

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

ADE LLC's AMGN Position: Q2 2026 in Review

ADE LLC held its Amgen (AMGN) position steady in Q2 2026 at 2,551 shares worth $924K. The position accounts for 0.39% of the portfolio, ranked #35.

ADE LLC first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. 3,154 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

ADE LLC held 2,551 shares of Amgen worth $924K as of Q2 2026.
ADE LLC left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.39% of ADE LLC's portfolio in Q2 2026, its #35 holding.
ADE LLC first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
3,154 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on ADE LLC's 13F filing for Q2 2026, filed 4 Aug 2026.